CX3CL1 and COVID-19: Other data have shown that the occurrence of new or more severe headaches due to COVID-19 elicited peripheral sensitization and microglial activation associated with serum changes in BDNF, TGF-ß1, VEGF, NGF, and CX3CL1 suggestive of long-lasting severe inflammation or immune dysregulation [111].